Medications such as Wegovy and Zepbound have helped many people lose weight by reducing appetite, slowing digestion, and improving blood-sugar regulation. Combined with lifestyle changes, these medications can lead to meaningful and sustainable weight loss.
Large clinical trials have shown significant average weight loss with GLP-1 medications, though individual responses vary. One of the most common questions patients ask is:
"Why has my weight loss stalled even though I'm still taking a GLP-1 medication?"
If you have hit a plateau, you are not alone. Weight loss with GLP-1 medications is rarely perfectly linear. Many patients have periods where the scale slows or temporarily stops before progress resumes again. Understanding why it happens helps determine what to do next.
Key takeaways
- Weight loss with GLP-1 medications is rarely perfectly linear.
- Temporary plateaus are common and do not necessarily mean the medication has stopped working.
- Individual responses vary based on metabolic and clinical factors.
- Protein intake, sleep, stress, and medication dose all influence progress.
- Addressing overall health alongside the medication often restarts progress.
Quick answer: why weight loss stalls on GLP-1s
Weight loss may slow or stall on GLP-1 medications like Wegovy or Zepbound for several common reasons:
- Natural metabolic adaptation as body weight decreases
- Individual variability in metabolic response to treatment
- Reduced muscle mass from low protein intake
- Medication dose that has not yet reached an optimal level
- Sleep or stress affecting metabolic regulation
- Hormonal changes that influence metabolism
Most plateaus are temporary. They typically improve with adjustments to nutrition, activity, sleep, or medication management.
How GLP-1 medications work
GLP-1 receptor agonists like Wegovy and Zepbound mimic the activity of glucagon-like peptide-1, a hormone involved in appetite regulation and glucose metabolism. They support weight loss by:
- Reducing appetite signals in the brain
- Slowing gastric emptying
- Improving insulin regulation
- Increasing feelings of fullness after eating
Clinical studies show that patients using GLP-1 medications for chronic weight management may lose approximately 10 to 20 percent of their body weight, though individual outcomes vary depending on metabolic, behavioral, and medical factors. Because weight regulation is influenced by many physiological systems, weight loss often happens in phases, and temporary plateaus are expected.
How much weight do people typically lose on GLP-1s?
Clinical trials have shown that patients using Wegovy and Zepbound may lose approximately 10 to 20 percent of body weight when the medication is combined with lifestyle changes. Weight loss typically occurs in phases: steady loss followed by temporary plateaus as the body adjusts, then further loss. The pattern is common and does not mean the medication has stopped working.
Common reasons weight loss stalls
1. Metabolic adaptation and individual response
During weight loss, the body naturally adjusts energy expenditure. This process is sometimes called metabolic adaptation: the body may require fewer calories to maintain a lower weight. Research also shows that responses to GLP-1 medications vary significantly between individuals. Factors associated with greater weight loss include:
- Female sex
- Younger age
- Higher baseline BMI
- Lower hemoglobin A1c
- Absence of hypertension
This variability is why temporary plateaus can occur even when the medication continues to support metabolic changes.
2. Low protein intake and muscle loss
GLP-1 medications often reduce appetite significantly. While that helps with weight loss, some people unintentionally eat too little protein. Protein plays an important role in preserving lean muscle mass during weight loss. If muscle mass decreases, metabolic rate can decline slightly, which contributes to slower progress on the scale.
Patients often benefit from:
- Prioritizing protein intake (most guidelines suggest aiming higher than you did pre-treatment)
- Maintaining balanced nutrition
- Incorporating resistance or strength training
Preserving muscle mass supports long-term metabolic health and body composition.
3. Medication dose may need adjustment
GLP-1 medications are typically started at a lower dose and gradually increased to improve tolerability and minimize side effects. Some patients experience slower weight loss if they haven't yet reached the dose that works best for their body. A healthcare provider can evaluate progress and determine whether a dose adjustment is appropriate based on response and tolerance.
4. Sleep and stress affect metabolism
Sleep quality and stress levels strongly influence metabolism and appetite regulation. Chronic stress and poor sleep can increase cortisol, a hormone associated with increased abdominal fat storage and changes in appetite regulation. Improving sleep habits and managing stress often helps support overall metabolic health and weight management.
5. Hormonal changes and metabolism
Hormonal changes during perimenopause and menopause can influence body composition, metabolism, and fat distribution. Many women notice that weight management becomes more challenging in midlife due to shifts in estrogen, changes in muscle mass, and alterations in energy balance. Research continues to explore how hormonal changes interact with GLP-1 medications specifically, but these metabolic shifts can influence overall weight-loss patterns, which is one reason we often evaluate hormonal health as part of weight management.
— Kim Wohlwend, MSN, APRN
Medical weight-loss care in Omaha and Papillion
Midwest Mind & Body Healthcare provides medically supervised weight-loss care for patients in Papillion, Omaha, Bellevue, and surrounding Nebraska communities. Our approach considers the connection between metabolism, hormones, and mental health. We offer personalized weight-loss programs using FDA-approved GLP-1 medications such as Wegovy and Zepbound. Both in-person visits in Papillion and telehealth appointments are available.
Frequently asked questions
Is it normal for weight loss to stall on GLP-1 medications?
Yes. Weight-loss plateaus are common with GLP-1 medications. Many patients experience periods where weight loss slows before continuing again.
How long do GLP-1 weight-loss plateaus last?
Plateaus may last several weeks. Adjustments to nutrition, activity, sleep, or medication dosing can help support continued progress.
Does a plateau mean the medication stopped working?
Not necessarily. Plateaus are often part of the normal weight-loss process as the body adapts to metabolic changes.
Evidence & References
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
- Jastreboff AM et al. Tirzepatide once weekly for treatment of obesity. New England Journal of Medicine. 2022.
- Rubino DM et al. Effect of continued weekly semaglutide vs placebo on weight maintenance. JAMA. 2021.
Stuck on a plateau? Let's figure out why.
GLP-1 therapy with real clinician oversight, not an automated telehealth app. $60 initial visit, $60 per refill. Telehealth in 16 states, in-person in Papillion.
Book an AppointmentThis content is for educational purposes only and does not replace medical advice. Treatment decisions are individualized and discussed during your visit.